[HTML][HTML] The post-translational modification, SUMOylation, and cancer

ZJ Han, YH Feng, BH Gu, YM Li… - … journal of oncology, 2018 - spandidos-publications.com
SUMOylation is a reversible post-translational modification which has emerged as a crucial
molecular regulatory mechanism, involved in the regulation of DNA damage repair, immune …

SUMO and the robustness of cancer

JS Seeler, A Dejean - Nature Reviews Cancer, 2017 - nature.com
Post-translational protein modification by small ubiquitin-like modifier (SUMO), termed
sumoylation, is an important mechanism in cellular responses to stress and one that …

SUMOylation-mediated regulation of cell cycle progression and cancer

K Eifler, ACO Vertegaal - Trends in biochemical sciences, 2015 - cell.com
Protein conjugation with Small ubiquitin-like modifier (SUMOylation) has critical roles during
cell cycle progression. Many important cell cycle regulators, including many oncogenes and …

Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor

X He, J Riceberg, T Soucy, E Koenig… - Nature chemical …, 2017 - nature.com
Small ubiquitin-like modifier (SUMO) family proteins regulate target-protein functions by post-
translational modification. However, a potent and selective inhibitor targeting the SUMO …

Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model

S Kumar, MJA Schoonderwoerd, JS Kroonen… - Gut, 2022 - gut.bmj.com
Objective Pancreatic ductal adenocarcinoma (PDAC) has the characteristics of high-density
desmoplastic stroma, a distinctive immunosuppressive microenvironment and is profoundly …

[HTML][HTML] A chain of events: regulating target proteins by SUMO polymers

NS Jansen, ACO Vertegaal - Trends in biochemical sciences, 2021 - cell.com
Small ubiquitin-like modifiers (SUMOs) regulate virtually all nuclear processes. The fate of
the target protein is determined by the architecture of the attached SUMO protein, which can …

SUMOylation in carcinogenesis

K Bettermann, M Benesch, S Weis, J Haybaeck - Cancer letters, 2012 - Elsevier
SUMOylation is a post-translational modification characterized by covalent and reversible
binding of small ubiquitin-like modifier (SUMO) to a target protein. In mammals, four different …

SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma

Z Wang, B Pan, L Su, H Yu, X Wu, Y Yao, X Zhang… - Cellular Oncology, 2024 - Springer
Purpose High levels of heterogeneity and immunosuppression characterize the HCC
immune microenvironment (TME). Unfortunately, the majority of hepatocellular carcinoma …

[HTML][HTML] Importance of glycolysis and oxidative phosphorylation in advanced melanoma

J Ho, MB de Moura, Y Lin, G Vincent, S Thorne… - Molecular cancer, 2012 - Springer
Serum lactate dehydrogenase (LDH) is a prognostic factor for patients with stage IV
melanoma. To gain insights into the biology underlying this prognostic factor, we analyzed …

Human pathogens and the host cell SUMOylation system

P Wimmer, S Schreiner, T Dobner - Journal of virology, 2012 - Am Soc Microbiol
Since posttranslational modification (PTM) by the small ubiquitin-related modifiers (SUMOs)
was discovered over a decade ago, a huge number of cellular proteins have been found to …